Cargando…
The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
In the era of precision medicine, cancer researchers and oncologists are eagerly searching for more realistic, cost effective, and timely tumor models to aid drug development and precision oncology. Tumor models that can faithfully recapitulate the histological and molecular characteristics of vario...
Autores principales: | Granat, Lauren M., Kambhampati, Ooha, Klosek, Stephanie, Niedzwecki, Brian, Parsa, Kian, Zhang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762043/ https://www.ncbi.nlm.nih.gov/pubmed/31773090 http://dx.doi.org/10.1002/ame2.12077 |
Ejemplares similares
-
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
por: Praharaj, Prakash P., et al.
Publicado: (2018) -
Patient-Derived Cancer Organoids for Precision Oncology Treatment
por: Pernik, Mark N., et al.
Publicado: (2021) -
Organoids as an Enabler of Precision Immuno-Oncology
por: Zhao, Junzhe, et al.
Publicado: (2023) -
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)